Skip to content

Selective bladder preservation with curative intent consisting of chemoradiotherapy plus partial cystectomy for muscle-invasive bladder cancer

Selective bladder preservation with curative intent consisting of chemoradiotherapy plus partial cystectomy for muscle-invasive bladder cancer - Bladder preservation consisting of chemoradiotherapy plus partial cystectomy for muscle-invasive bladder cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000015076
Enrollment
200
Registered
2014-09-12
Start date
2008-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle-invasive bladder cancer

Interventions

Low-dose chemoratiation therapy Partial cystectomy

Sponsors

Department of Urology, Tokyo Medical and Dental University Graduate School
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Muscle-invasive bladder cancer (cT2-3N0M0) No involvement of the bladder neck Response to induction chemoradiation therapy

Exclusion criteria

Exclusion criteria: CIS Unfit for low-dose chemoradiation therapy or radical surgery under general anesthesia due to complications

Design outcomes

Primary

MeasureTime frame
Muscle-invasive bladder cancer-free survival in patients with bladder preservation

Secondary

MeasureTime frame
Cancer specific survival, Overall survival, Recurrence-free survival, bladder preservation rate, QOL in patients with bladder preservation, Clinical and pathological effect of TURBT + low-dose chemoradiation

Countries

Japan

Contacts

Public ContactYasuhisa Fujii

Tokyo Medical and Dental University Urology

y-fujii.uro@tmd.ac.jp03-5803-5295

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026